Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 9 Neoplasms 3 Pancreatic Cancer Metastatic 1 Neoplasm Metastasis 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Adenocarcinoma 1

Interventions

Bevacizumab 101 Fluorouracil 88 Leucovorin 86 Oxaliplatin 85 Irinotecan 76 Capecitabine 65 Cetuximab 54 Panitumumab 35 pembrolizumab 33 regorafenib 25 Nivolumab 22 Folfox protocol 19 IFL protocol 17 trifluridine tipiracil drug combination 11 durvalumab 11 Radiotherapy 11 Gemcitabine 8 tremelimumab 7 aflibercept 7 Cyclophosphamide 7 Celecoxib 7 binimetinib 6 Sunitinib 6 Drug Therapy 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6 cediranib 5 Trifluridine 5 Surgical Procedures, Operative 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03828799 2026-02-27

FOLFIRINOX-R

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡